Maria Cristina de Oliveira Izar

ORCID: 0000-0002-5738-2623
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Atherosclerosis and Cardiovascular Diseases
  • Blood Pressure and Hypertension Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiovascular Function and Risk Factors
  • Cancer, Lipids, and Metabolism
  • Acute Myocardial Infarction Research
  • Public Health in Brazil
  • Nutritional Studies and Diet
  • Cardiac Imaging and Diagnostics
  • Diet and metabolism studies
  • Cholesterol and Lipid Metabolism
  • Cardiovascular Disease and Adiposity
  • Healthcare Regulation
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antioxidant Activity and Oxidative Stress
  • Global Public Health Policies and Epidemiology
  • Coronary Interventions and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Cardiovascular Health and Disease Prevention
  • Health and Lifestyle Studies
  • Inflammatory Biomarkers in Disease Prognosis
  • Obesity, Physical Activity, Diet

Universidade Federal de São Paulo
2016-2025

Universidade de São Paulo
2012-2024

Sociedade Brasileira de Cardiologia
2007-2024

National Institute of Science and Technology Complex Fluids
2012-2024

Hospital São Paulo
2023

Sociedade Brasileira de Diabetes
2022

Universidade de Santo Amaro
2022

Instituto do Coração
2021

ORCID
2021

Hospital Israelita Albert Einstein
2021

10.1590/s0066-782x2007000700002 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2007-04-01

O Departamento de Aterosclerose da Sociedade Brasileira Cardiologia (SBC), acompanhando o amplo cenário publicações científicas sobre tratamento das dislipidemias e prevenção aterosclerose, bem como a importância seu impacto risco cardiovascular, reconhecendo necessidade atualização sua última diretriz, publicada em 2013, conformidade com as recomendações SBC, reuniu um comitê especialistas, clínica do laboratório clínico, partir janeiro 2016, para elaboração deste documento, que ora...

10.5935/abc.20170121 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2017-01-01
Dalton Bertolim Précoma Gláucia Maria Moraes de Oliveira Antônio Felipe Simão Óscar Pereira Dutra Otávio Rizzi Coelho-Filho and 71 more Maria Cristina de Oliveira Izar Rui Póvoa Isabela de Carlos Back Giuliano Aristóteles Comte de Alencar Filho Carlos Alberto Machado Carlos Scherr Francisco Antônio Helfenstein Fonseca Raul Dias dos Santos Filho Tales de Carvalho Álvaro Avezum Roberto Esporcatte Bruno Ramos Nascimento David Brasil Gabriel Porto Soares Paolo Blanco Villela Roberto Muniz Ferreira Wolney de Andrade Martins Andrei C. Spósito Bruno Halpern José Francisco Kerr Saraiva Luiz Sérgio Fernandes de Carvalho Marcos Antônio Tambascia Otávio R. Coelho‐Filho Adriana Bertolami Harry Correa Filho Hermes Tóros Xavier José Rocha Faria‐Neto Marcelo Chiara Bertolami Viviane Z. Rocha Andréa Araújo Brandão Audes D. M. Feitosa Celso Amodeo Dilma do Socorro Moraes de Souza Eduardo Costa Duarte Barbosa Marcus Vinícius Bolívar Malachias Weimar Kunz Sebba Barroso Fernando Augusto Alves da Costa Iván Romero Rivera Lúcia Campos Pellanda Maria Alayde Mendonça da Silva Aloyzio Achutti André Ribeiro Langowiski Carla Janice Baister Lantieri Jaqueline Schölz Issa Silvia Maria Cury Ismael José Carlos Aidar Ayoub Luiz César Nazário Scala Mário Fritsch Neves Paulo César Brandão Veiga Jardim Sandra Cristina Pereira Costa Fuchs Thiago Veiga Jardim Emílio Hideyuki Moriguchi Jamil Cherem Schneider Marcelo Heitor Vieira Assad Sérgio Kaiser Ana Maria Lottenberg Daniel Magnoni Márcio H. Miname Ricardo Henrique Veppo Lara Artur Haddad Herdy Cláudio Gil Soares de Araújo Maurício Milani Miguel Morita Fernandes-Silva Ricardo Stein Fernando Lucchese Fernando Nobre Hermilo Borba Griz Lucélia Batista Neves Cunha Magalhães Mário Henrique Elesbão de Borba Mauro Ricardo Nunes Pontes Ricardo Mourilhe‐Rocha

Introducao A doenca cardiovascular (DCV) e a principal causa de morte no Brasil mundo, determinando aumento da morbidade incapacidade ajustadas pelos anos vida. Embora as taxas mortalidade disability-adjusted life year (DALY) padronizadas por idade estejam diminuindo Brasil, possivelmente como resultado politicas saude bem-sucedidas, o numero total destas esta aumentando principalmente devido ao envelhecimento adoecimento populacao. presenca dos fatores risco classicos (hipertensao,...

10.5935/abc.20190204 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2019-01-01
Katherine Wilemon Jasmine Patel Carlos A. Aguilar‐Salinas Catherine D. Ahmed Mutaz Al-Khnifsawi and 84 more Wael Almahmeed Rodrigo Alonso Khalid Al‐Rasadi Lina Badimón Luz Mery Bernal Martin P. Bogsrud Lynne T. Braun Liam R. Brunham Alberico L. Catapano Kristýna Cillíková Pablo Corral Regina Cuevas Joep C. Defesche Olivier Descamps Sarah D. de Ferranti Jean-Luc Eiselé Gerardo Elikir Emanuela Folco Tomáš Freiberger Francesco Fuggetta Isabel Gaspar Ákos G. Gesztes Urh Grošelj Ian Hamilton‐Craig Gabriele Hanauer-Mader Mariko Harada‐Shiba G. E. Hastings G. Kees Hovingh Maria Cristina de Oliveira Izar Allison Jamison Gunnar N. Karlsson Meral Kayıkçıoğlu Sue Koob Masahiro Koseki Stacey Lane Marcos M. Lima-Martínez Greizy López Tânia Leme da Rocha Martinez David Marais Letrillart Marion Pedro Mata Inese Maurina Diana Maxwell Roopa Mehta George A. Mensah André R. Miserez Dermot Neely Stephen J. Nicholls Atsushi Nohara Børge G. Nordestgaard Leiv Ose Athanasios Pallidis Jing Pang Jules Payne Amy L. Peterson Monica P. Popescu Raman Puri Kausik K. Ray Ashraf Reda Tiziana Sampietro Raúl D. Santos Inge Schalkers Laura Schreier Michael D. Shapiro Eric J.G. Sijbrands Daniel Soffer Claudia Stefanutti Mario Stoll Rody G. Sy Marta Lucía Tamayo Myra Tilney Lâle Tokgözoğlu Brian Tomlinson Antonio J. Vallejo‐Vaz Alejandra Vázquez-Cárdenas Patrícia Vieira de Luca David S Wald Gerald F. Watts Nanette K. Wenger M. Allison Wolf David A. Wood Aram Zegerius Thomas A. Gaziano Samuel S. Gidding

<h3>Importance</h3> Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity mortality due atherosclerotic cardiovascular disease. affects 1 in 200 250 people around the world of every race ethnicity. The lack general awareness FH among public medical community has resulted only 10% population being diagnosed adequately treated. World Health Organization recognized as a health priority 1998 during consultation meeting Geneva,...

10.1001/jamacardio.2019.5173 article EN JAMA Cardiology 2020-01-02

Background: Increased numbers of endothelial (EMP) and platelet (PMP) microparticles have been related to cardiovascular risk factors coronary artery disease. Little is known about the early effects statins clopidogrel on these new biomarkers vascular homeostasis. The aim present study was evaluate pharmacokinetic interactions between atorvastatin their effects, alone or combined, EMP, PMP, progenitor cells (EPC). Methods Results: A prospective open-label enrolled subjects with stable...

10.1253/circj.cj-11-1145 article EN Circulation Journal 2011-12-28

I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)Definição do grau dos níveis evidência RecomendaçõesClasse I: Condições para as quais há evidências conclusivas e, na sua falta, consenso geral que o procedimento é

10.5935/abc.20120202 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2012-01-01

Cardiovascular events have been reported among HIV-infected patients following antiretroviral therapy. However, the role of HIV itself in determining vascular damage is less described. Chronic inflammatory state might impair some regulatory endothelium properties leading to its activation, apoptosis or erosion.To evaluate balance between endothelial progenitor cells and microparticles drug-naive patients.A case-control study comparing (n = 35) with sex-matched age-matched healthy controls...

10.1097/qad.0b013e32834980f4 article EN AIDS 2011-06-14

Resumo Fundamentação: desde o primeiro posicionamento da Sociedade Brasileira de Diabetes (SBD) sobre diabetes e prevenção cardiovascular, em 2014,1 importantes estudos têm sido publicados na área cardiovascular tratamento do diabetes,2 os quais contribuíram para a evolução primária secundária nos pacientes com diabetes. Ferramentas estratificação risco mais precisas, novos fármacos hipolipemiantes antidiabéticos efeitos cardiovasculares redução mortalidade, são parte desta nova abordagem O...

10.5935/abc.20170188 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2017-01-01

<h3>Importance</h3> Studies have found that patients at high cardiovascular risk often fail to receive evidence-based therapies in community practice. <h3>Objective</h3> To evaluate whether a multifaceted quality improvement intervention can improve the prescription of therapies. <h3>Design, Setting, and Participants</h3> In this 2-arm cluster randomized clinical trial, with established atherothrombotic disease from 40 public private outpatient clinics (clusters) Brazil were studied....

10.1001/jamacardio.2019.0649 article EN JAMA Cardiology 2019-04-03

It has been demonstrated that statins can increase intestinal sterol absorption. Augments in phytosterolemia seems related to cardiovascular disease.We examined the role of soluble fiber intake endogenous cholesterol synthesis and absorption among subjects under highly effective lipid-lowering therapy.In an open label, randomized, parallel-design study with blinded endpoints, primary hypercholesterolemia (n = 116) were assigned receive during 12 weeks, a daily dose 25 g (corresponding 6...

10.1186/1475-2891-10-80 article EN cc-by Nutrition Journal 2011-08-02

Justificativas A revisao da necessidade do jejum para determinacao perfil lipidico (colesterol total, LDL-C, HDL-C, nao-HDL-C e triglicerides [TG]) baseia-se nas seguintes justificativas: […] Posicionamento sobre a Flexibilizacao Jejum o Perfil Lipidico

10.5935/abc.20170039 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2017-01-01

Diabetes mellitus is a global epidemic, characterised as heterogeneous group of metabolic disorders associated with high risk CVD. Green banana biomass, which composed resistant starches (RS) and cannot be hydrolysed by amylases, delays gastric emptying modulates insulin sensitivity, thus contributing to improve disorders. The aim the present study was investigate effects consumption RS from green biomass on body composition, fasting plasma glucose, glycated Hb (HbA1c) homeostasis model...

10.1017/s0007114519000576 article EN British Journal Of Nutrition 2019-03-19
Coming Soon ...